Ablation of the Complementarity-Determining Region H3 Apex of the Anti-HIV-1 Broadly Neutralizing Antibody 2F5 Abrogates Neutralizing Capacity without Affecting Core Epitope Binding

被引:59
作者
Julien, Jean-Philippe [1 ]
Huarte, Nerea [4 ,5 ]
Maeso, Ruben [4 ,5 ]
Taneva, Stefka G. [4 ]
Cunningham, Annie [1 ]
Nieva, Jose L. [4 ,5 ]
Pai, Emil F. [1 ,2 ,3 ]
机构
[1] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Med Biophys & Mol Genet, Toronto, ON M5S 1A8, Canada
[3] Princess Margaret Hosp, Ontario Canc Inst, Campbell Family Inst Canc Res, MaRS TMDT, Toronto, ON M5G 1L7, Canada
[4] Univ Basque Country, CSIC, EHU, Unidad Biofis, E-48080 Bilbao, Spain
[5] Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain
关键词
MONOCLONAL-ANTIBODY; ANTI-GP41; 2F5; HEAVY-CHAIN; HIV-1; MEMBRANE; GP41; VACCINE; RECOGNITION; ANTIGEN; 4E10;
D O I
10.1128/JVI.02357-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The identification and characterization of broadly neutralizing antibodies (bnAbs) against HIV-1 has formed a major research focus, with the ultimate goal to help in the design of an effective AIDS vaccine. One of these bnAbs, 2F5, has been extensively characterized, and residues at the apex of its unusually long complementarity-determining region (CDR) H3 loop have been shown to be crucial for neutralization. Structural studies, however, have revealed that the (100)TLFGVPI(100)F apex residues of the CDR H3 loop do not interact directly with residues of its core gp41 epitope. In an attempt to gain better insight into the functional role of this element, we have recombinantly expressed native 2F5 Fab and two mutants in which either the apical Phe100B(H) residue was changed to an alanine or the CDR H3 residues (100)TLFGVPI(100)F were replaced by a Ser-Gly dipeptide linker. Isothermal titration calorimetry (ITC) and competitive-binding enzyme-linked immunosorbent assays (ELISAs) rendered strikingly similar affinity constants (K-d [dissociation constant] of similar to 20 nM) for linear peptide epitope binding by 2F5 Fabs, independent of the presence or absence of the apex residues. Ablation of the CDR H3 apex residues, however, abolished the cell-cell fusion inhibition and pseudovirus neutralization capacities of 2F5 Fab. We report competitive ELISA data that suggest a role of 2F5 CDR H3 apex residues in mediating weak hydrophobic interactions with residues located at the C terminus of the gp41 membrane proximal external region and/or membrane components in the context of core epitope binding. The present data therefore imply an extended 2F5 paratope that includes weak secondary interactions that are crucial for neutralization of Env-mediated fusion.
引用
收藏
页码:4136 / 4147
页数:12
相关论文
共 60 条
  • [1] Abramoff M.D., 2004, Biophotonics International, V11, P36
  • [2] The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes
    Alam, S. Munir
    McAdams, Mildred
    Boren, David
    Rak, Michael
    Scearce, Richard M.
    Gao, Feng
    Camacho, Zenaido T.
    Gewirth, Daniel
    Kelsoe, Garnett
    Chen, Pojen
    Haynes, Barton F.
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (07) : 4424 - 4435
  • [3] Role of HIV membrane in neutralization by two broadly neutralizing antibodies
    Alam, S. Munir
    Morelli, Marco
    Dennison, S. Moses
    Liao, Hua-Xin
    Zhang, Ruijun
    Xia, Shi-Mao
    Rits-Volloch, Sophia
    Sun, Li
    Harrison, Stephen C.
    Haynes, Barton F.
    Chen, Bing
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (48) : 20234 - 20239
  • [4] Protective immunity following vaccination
    Amanna, Ian J.
    Messaoudi, Ilhem
    Slifka, Mark K.
    [J]. HUMAN VACCINES, 2008, 4 (04): : 316 - 319
  • [5] Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope
    Arnold, Gail Ferstandig
    Velasco, Paola K.
    Holmes, Andrew K.
    Wrin, Terri
    Geisler, Sheila C.
    Phung, Pham
    Tian, Yu
    Resnick, Dawn A.
    Ma, Xuejun
    Mariano, Thomas M.
    Petropoulos, Christos J.
    Taylor, John W.
    Katinger, Hermann
    Arnold, Eddy
    [J]. JOURNAL OF VIROLOGY, 2009, 83 (10) : 5087 - 5100
  • [6] Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications
    Bryson, Steve
    Julien, Jean-Philippe
    Hynes, Rosemary C.
    Pai, Emil F.
    [J]. JOURNAL OF VIROLOGY, 2009, 83 (22) : 11862 - 11875
  • [7] Antibody vs. HIV in a clash of evolutionary titans
    Burton, DR
    Stanfield, RL
    Wilson, IA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (42) : 14943 - 14948
  • [8] HIV vaccine design and the neutralizing antibody problem
    Burton, DR
    Desrosiers, RC
    Doms, RW
    Koff, WC
    Kwong, PD
    Moore, JP
    Nabel, GJ
    Sodroski, J
    Wilson, IA
    Wyatt, RT
    [J]. NATURE IMMUNOLOGY, 2004, 5 (03) : 233 - 236
  • [9] Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
    Calarese, DA
    Scanlan, CN
    Zwick, MB
    Deechongkit, S
    Mimura, Y
    Kunert, R
    Zhu, P
    Wormald, MR
    Stanfield, RL
    Roux, KH
    Kelly, JW
    Rudd, PM
    Dwek, RA
    Katinger, H
    Burton, DR
    Wilson, IA
    [J]. SCIENCE, 2003, 300 (5628) : 2065 - 2071
  • [10] Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41
    Cardoso, RMF
    Zwick, MB
    Stanfield, RL
    Kunert, R
    Binley, JM
    Katinger, H
    Burton, DR
    Wilson, IA
    [J]. IMMUNITY, 2005, 22 (02) : 163 - 173